Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Dedifferentiation of MCF-7 Breast Cancer Continuous Cell Line, Development of Breast Cancer Stem Cells (BCSCs) Enriched Culture and Biomarker Analysis

The Indonesian Biomedical Journal · Vol. 12 No. 2 (2020) · hlm. 115–123

DOI
10.18585/inabj.v12i2.977
ISSN
2085-3297, 2355-9179
Terbit
2020-06-29
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Cancer stem cells (CSCs) eradication might serve as a robust approach for cancer eradication. MCF-7 as breast cancer continuous cell line is known to contain breast CSCs (BCSCs) for its capability to maintain its original tumor population. CSCs enriched culture is a fundamental tool for CSCs targeted therapy development. Effective and unsophisticated CSCs dedifferentiation protocol for producing CSCs enriched culture is needed.METHODS: MCF-7 cells were cultured initially in Dulbecco's Modified Eagle Medium (DMEM) low glucose medium then changed to DMEM:F12. Serum starvation was performed during each medium refreshment gradually with fetal bovine serum (FBS) concentration of 10%, 5%, 2.5% until reaching 1% FBS concentration. Stable MCF-7 culture was then adapted to serum free culture system, containing DMEM:F12, epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), and B27 supplement as dedifferentiation protocol for 18 days. Cluster of differentiation (CD)44 and CD24 double staining immunocytochemistry was performed to evaluate cell stemness.RESULTS: The population of cells expressing BCSCs markers (CD44+/CD24low) in non-adherent single cells subpopulation was significantly increased after the dedifferentiation procedure (70.39%) compared to control groups (0.71%) (p<0.05). In contrast, the expression of BCSCs marker in adherent single cells subpopulation and for both adherent and non-adherent mammosphere the BCSCs markers showed a stable expression.CONCLUSION: BCSCs enrichment of breast cancer cell cultures from MCF-7 breast cancer cell line can be performed. Breast cancer cell plasticity is observed during the dedifferentiation protocol. Development of dedifferentiation inducing protocols can serve as an important foundation for breast cancer therapy development through BCSCs elimination.KEYWORDS: breast neoplasms, cell line, dedifferentiation, immunohistochemistry, neoplastic stem cells

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 116 tautan kepenulisan bersama · 41 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Sultan Agung Islamic University
  • Universitas Jember
  • Ollscoil na Gaillimhe – University of Galway
  • Rumah Sakit Dokter Soetomo
  • Bandung Institute of Technology
  • Universiti Sains Islam Malaysia
  • Organisasi lain
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Merlyna SavitriUniversitas Airlangga4
Pradana Zaky RomadhonUniversitas Airlangga4
Putu Niken Ayu AmritaUniversitas Airlangga4
Viskasari Pintoko KalanjatiUniversitas Airlangga3
Sri Agus SudjarwoUniversitas Airlangga3
Aucky HintingUniversitas Airlangga3
Bambang Edi SuwitoUniversitas Airlangga2
Dzanuar RahmawanUniversitas Airlangga2
Kusnoto KusnotoUniversitas Airlangga2
Jola RahmahaniUniversitas Airlangga2
Erna Dwi WahyuniUniversitas Airlangga2
Hamdani LunardhiUniversitas Airlangga2
Doddy Moesbadianto SoebadiUniversitas Airlangga2
Retno Pudji RahayuUniversitas Airlangga2
Sri HernawatiUniversitas Jember2
F. FerdiansyahRumah Sakit Dokter Soetomo1
Desi Sandra SariUniversitas Jember1
Ernie MaduratnaUniversitas Airlangga1
I Ketut SudianaUniversitas Airlangga1
Faurier Dzar Eljabbar LatiefBandung Institute of Technology1
Utari KresnoadiUniversitas Airlangga1
Amiyatun NainiUniversitas Jember1
Mohammad RubiantoUniversitas Airlangga1
Seno PradopoUniversitas Airlangga1
Sandy ChristionoSultan Agung Islamic University1
Islamy Rahma HutamiSultan Agung Islamic University1
Regilia Shinta MayangsariSultan Agung Islamic University1
Yayun Siti RochmahSultan Agung Islamic University1
Zurairah IbrahimUniversiti Sains Islam Malaysia1
Romaniyanto RomaniyantoRSO Soeharso Surakarta1
Cita Rosita Sigit PrakoeswaUniversitas Airlangga1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Dedifferentiation of MCF-7 Breast Cancer Continuous Cell Line, Development of Breast Cancer Stem Cells (BCSCs) Enriched Culture and Biomarker Analysis</dc:title><dc:creator>Ami Ashariati</dc:creator><dc:creator>Andi Yasmin Wijaya</dc:creator><dc:creator>Winona May Hendrata</dc:creator><dc:creator>Steven Sheng Looi</dc:creator><dc:creator>Reny I’tishom</dc:creator><dc:creator>Lukman Hakim</dc:creator><dc:creator>Fedik Abdul Rantam</dc:creator><dc:creator>I Ketut Sudiana</dc:creator><dc:creator>Abdurachman Abdurachman</dc:creator><dc:subject>breast cancer stem cells</dc:subject><dc:subject>MCF-7 cells</dc:subject><dc:subject>dedifferentiation</dc:subject><dc:subject>serum deprivation</dc:subject><dc:subject>serum-free culture</dc:subject><dc:subject>CD44</dc:subject><dc:subject>CD24</dc:subject><dc:subject>mammospheres</dc:subject><dc:subject>cellular plasticity</dc:subject><dc:subject>cancer stem cell markers</dc:subject><dc:description xml:lang="en">BACKGROUND: Cancer stem cells (CSCs) eradication might serve as a robust approach for cancer eradication. MCF-7 as breast cancer continuous cell line is known to contain breast CSCs (BCSCs) for its capability to maintain its original tumor population. CSCs enriched culture is a fundamental tool for CSCs targeted therapy development. Effective and unsophisticated CSCs dedifferentiation protocol for producing CSCs enriched culture is needed.METHODS: MCF-7 cells were cultured initially in Dulbecco's Modified Eagle Medium (DMEM) low glucose medium then changed to DMEM:F12. Serum starvation was performed during each medium refreshment gradually with fetal bovine serum (FBS) concentration of 10%, 5%, 2.5% until reaching 1% FBS concentration. Stable MCF-7 culture was then adapted to serum free culture system, containing DMEM:F12, epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), and B27 supplement as dedifferentiation protocol for 18 days. Cluster of differentiation (CD)44 and CD24 double staining immunocytochemistry was performed to evaluate cell stemness.RESULTS: The population of cells expressing BCSCs markers (CD44+/CD24low) in non-adherent single cells subpopulation was significantly increased after the dedifferentiation procedure (70.39%) compared to control groups (0.71%) (p&lt;0.05). In contrast, the expression of BCSCs marker in adherent single cells subpopulation and for both adherent and non-adherent mammosphere the BCSCs markers showed a stable expression.CONCLUSION: BCSCs enrichment of breast cancer cell cultures from MCF-7 breast cancer cell line can be performed. Breast cancer cell plasticity is observed during the dedifferentiation protocol. Development of dedifferentiation inducing protocols can serve as an important foundation for breast cancer therapy development through BCSCs elimination.KEYWORDS: breast neoplasms, cell line, dedifferentiation, immunohistochemistry, neoplastic stem cells</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2020-06-29</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v12i2.977</dc:identifier><dc:identifier>10.18585/inabj.v12i2.977</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 12 No 2 (2020); 115-123</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/977/473</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>